Chuang Mei Pharmaceutical (02289.HK) announces its interim performance: the net profit attributable to the parent company is 21.739 million yuan, a decrease of 18.72% year-on-year.

Wisetrend Financial News APP: Chuangmei Pharmaceutical (02289.HK) released its interim financial results for the six months ended June 30, 2025. The total operating income was 2.155 billion yuan, a year-on-year decrease of 8.18%; net profit attributable to shareholders was 21.739 million yuan, a year-on-year decrease of 18.72%; and basic earnings per share were 0.2013 yuan.